^
    Back
    Association details:
    Biomarker:CYB5A rs1790834
    Cancer:Prostate Cancer
    Drug:abiraterone acetate (CYP17A1 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    Source:
    Pharmgenomics Pers Med
    Title:

    Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients

    Published date:
    06/04/2020
    Excerpt:
    The SNP rs1790834 on CYB5A showed significant association with PSA response in CRPC patients treated with AA/P (P < 0.05)…
    DOI:
    10.2147/PGPM.S245086